Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
2701 Eastlake Ave East, Seattle, WA
Fiscal year end
December 31
Former names
ARYA Sciences Acquisition Corp III (to 6/8/2021)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.85K % -10.6%
Debt-to-equity 16 % +10.6%
Return On Equity -30.9 % -37.7%
Return On Assets -26.6 % -35.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +0.71%
Common Stock, Shares, Outstanding 126M shares +0.83%
Entity Public Float 113M USD -48.4%
Common Stock, Value, Issued 13K USD 0%
Weighted Average Number of Shares Outstanding, Basic 125M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +0.41%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 50.5M USD +6.83%
General and Administrative Expense 31M USD +7.26%
Nonoperating Income (Expense) 10.7M USD -14.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -70.8M USD -11.2%
Earnings Per Share, Basic -0.56 USD/shares -9.8%
Earnings Per Share, Diluted -0.56 USD/shares -9.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.6M USD +42.5%
Cash, Cash Equivalents, and Short-term Investments 130M USD -25.1%
Assets, Current 133M USD -24.9%
Property, Plant and Equipment, Net 4.08M USD -4.48%
Operating Lease, Right-of-Use Asset 28.3M USD -13.4%
Other Assets, Noncurrent 1.18M USD 0%
Assets 243M USD -20.6%
Accounts Payable, Current 987K USD -39.8%
Employee-related Liabilities, Current 1.34M USD -48.1%
Liabilities, Current 7.63M USD -16.3%
Operating Lease, Liability, Noncurrent 26.4M USD -15.1%
Liabilities 34M USD -15.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 57K USD
Retained Earnings (Accumulated Deficit) -273M USD -35%
Stockholders' Equity Attributable to Parent 209M USD -21.3%
Liabilities and Equity 243M USD -20.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -29.9%
Net Cash Provided by (Used in) Financing Activities 245K USD
Net Cash Provided by (Used in) Investing Activities 22.4M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 126M shares +0.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.33M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.6M USD +40.4%
Deferred Tax Assets, Valuation Allowance 78.4M USD +34.6%
Deferred Tax Assets, Gross 85.9M USD +28.5%
Operating Lease, Liability 30.5M USD -12%
Depreciation 1.98M USD +6.81%
Payments to Acquire Property, Plant, and Equipment 647K USD -6.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -70.5M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid 39.4M USD -15.1%
Property, Plant and Equipment, Gross 10.6M USD +19.2%
Operating Lease, Liability, Current 4.1M USD +15.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.87M USD -4.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.59M USD +2.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.9M USD -24.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.89M USD +0.16%
Deferred Tax Assets, Operating Loss Carryforwards 32.7M USD +51.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 3.15M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.82M USD -15.6%
Operating Lease, Payments 1.7M USD +41.7%
Additional Paid in Capital 482M USD +2.96%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.56M USD -12.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%